Google DeepMind Releases AlphaGenome 2 for Cell-Level Disease Research
Google DeepMind has introduced AlphaGenome 2, an AI model that predicts how DNA variants affect specific human cell types and states. The model is available through an API for noncommercial research and is intended to aid disease research and drug development.
Google DeepMind Releases AlphaGenome 2 for Cell-Level Disease Research
Write a comment